Fig. S1 Supplémentaire de la thérapie endocrinienne synergie avec les mimétiques SMAC pour potentialiser la présentation d'antigènes et la régression tumorale dans le cancer du sein hormono-dépendant

Hermida‐Prado et al. (Mon,) ont étudié cette question.

www.synapsesocial.com/papers/68e586b5b6db643587523181 — DOI: https://doi.org/10.1158/0008-5472.27028630

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Fig. S1 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
2. Supplementary Fig. S2 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
3. Supplementary Fig. S2 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
4. Supplementary Fig. S5 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024
5. Supplementary Fig. S5 from Endocrine therapy synergizes with SMAC mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer· 2024